The Psilocybin Layer 5 Finding Changes How I Think About What We’re Actually Dosing For
A Nature Neuroscience study separates psilocybin's neuroplastic effects from its hallucinogenic ones, and it should reshape how we design...
Editor's Choice
When Payer Status Becomes a Protocol Variable: What the Medicare Advantage Transplant Gap Means for ESKD Trial Enrollment
MA beneficiaries received kidney transplants at nearly half the rate of traditional Medicare patients post-Cures Act, a disparity that...
Pelacarsen Lowered the Biomarker. It Did Not Save Lives. Now What?
Novartis's pelacarsen hit its Lp(a) target in 8,323 patients but missed the cardiovascular endpoint entirely, exposing a $6B assumption...
YPrime Names Greg Wellbrock Chief Data and AI Officer
YPrime names Greg Wellbrock Chief Data and AI Officer to lead unified data and AI strategy across its clinical...
Arcus Biosciences reports $694M cash for pipeline advancement through pivotal trials
Arcus Biosciences has $694M in cash to advance its pipeline through pivotal trials, including the Phase 3 PRISM-1 study...
Fifth Circuit Vacates Class Certification in Filana Therapeutics Securities Case
Fifth Circuit vacates class certification in Filana Therapeutics securities case, removing litigation overhang as company advances simufilam clinical program.
FDA Clears Fresenius multiFiltratePRO for Regional Citrate Anticoagulation
FDA clears Fresenius multiFiltratePRO for regional citrate anticoagulation in acute kidney injury, with integrated pumps and dedicated solutions for...
Why Pharma’s AI Future Depends on Standardization First
At its annual Summit, Veeva unveiled a flat-rate pricing model for Vault AI, introduced Falcon agentic labor tools, and...
FDA AI Guidance Requires Sponsors to Validate Clinical Trial Algorithms
FDA AI Guidance requires clinical trial sponsors to validate algorithms before submission, shifting documentation and testing burdens based on...
NFL funds $500K study into elevated ALS risk in athletes, veterans, first responders
NFL funds $500K study into elevated ALS risk in athletes, veterans, and first responders to identify genetic and biological...